AMCPR (Augmented-Medication CardioPulmonary Resuscitation) Trial for OHCA

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
The investigators aimed to evaluate the effect of AMCPR (Augmented-Medication CardioPulmonary Resuscitation: administration of additional vasopressin to titrate to arterial diastolic blood pressure over 20 mmHg) on cardiopulmonary resuscitation results and outcomes in out-of-hospital cardiac arrest patients.
Epistemonikos ID: 4d4f2f2bc07114d8ff32476d052c89681581c07c
First added on: May 20, 2024